IL15 and acute myeloid leukemia: It is surprising that C-JUN outperforms other factors (ZAP70, LCK, IL-15, etc.)reported to promote CAR T function31–33,46,47 and can significantly promote CAR T therapeutic efficacy in AML disease model.